Who
Tuan Tu Diep
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Skye Bioscience.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $98K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Feb 2024
- Last trade
- 31 Mar 2026
- Last filed
- 2 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —8,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,080 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —7,080 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —75,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —150,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,194 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —150,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,194 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —9,194 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,021 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,021 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —125,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —8,000 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,080 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code D | —7,080 | filing |
News
No headline names them, or the companies they trade most, lately.